ABSINasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Absci Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$8.54+0.29 (+3.52%)
Close on Oct 19, 2026
- Market cap
- $1.34B
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
88.3%
151M of 172M shares
Institutional holders
197
51 new, 15 sold out
Net institutional buying
25M
In Q2 2026
Insider trades, 12 months
5 buys · 2 sales
Net bought $800.85K
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Phoenix General Partner II LLC | 9,354,695 | 8.20% | 13G (passive) amendment | Sep 30, 2024 |
| BlackRock, Inc. | 8,319,387 | 6.50% | 13G (passive) amendment | Jun 30, 2025 |
| ARK Investment Management LLC | 8,265,935 | 7.20% | 13G (passive) amendment | Dec 31, 2024 |
| Redmile Group, LLC | 8,253,316 | 5.40% | 13D (active) amendment | Mar 24, 2026 |
| FMR LLC | 18,386,849 | 14.40% | 13G (passive) amendment | Mar 31, 2025 |
| Sean McClain | 11,002,709 | 7.20% | 13G (passive) amendment | Sep 30, 2025 |
| Catherine D. Wood | 10,955,089 | 8.60% | 13G (passive) amendment | Mar 31, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of ABSI | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| FMR LLC | 25,410,048 | 14.81% | $294.50M | +2,859,051 | 0.01% |
| ARK Investment Management LLC | 12,925,271 | 7.53% | $149.80M | −800,898 | 0.97% |
| BlackRock, Inc. | 12,175,302 | 7.09% | $141.11M | +920,108 | 0.00% |
| State Street Corp | 8,097,308 | 4.72% | $93.85M | +772,450 | 0.00% |
| Ameriprise Financial Inc | 6,991,763 | 4.07% | $81.03M | +3,811,622 | 0.02% |
| Redmile Group, LLC | 6,739,675 | 3.93% | $78.11M | −1,513,641 | 5.24% |
| Vanguard Capital Management LLC | 6,122,677 | 3.57% | $70.96M | +236,037 | 0.00% |
| Advanced Micro Devices Inc | 5,714,285 | 3.33% | $66.23M | – | 5.05% |
| Adage Capital Partners Gp, L.L.C. | 5,704,820 | 3.32% | $66.12M | New | 0.09% |
| Two Sigma Investments, LP | 5,493,486 | 3.20% | $63.67M | +2,594,720 | 0.05% |
| D. E. Shaw & Co., Inc. | 5,239,754 | 3.05% | $60.73M | +4,589,937 | 0.03% |
| Geode Capital Management, LLC | 3,583,163 | 2.09% | $41.54M | +240,095 | 0.00% |
| Woodline Partners LP | 2,700,675 | 1.57% | $31.30M | −599,494 | 0.10% |
| Siren, L.L.C. | 2,474,764 | 1.44% | $28.68M | +674,764 | 0.58% |
| Bvf Inc/Il | 2,361,674 | 1.38% | $27.37M | New | 0.70% |
| Gem Investment Advisors, LLC | 2,170,863 | 1.26% | $25.16M | – | 15.43% |
| Baker Bros. Advisors LP | 2,134,803 | 1.24% | $24.74M | – | 0.12% |
| Goldman Sachs Group Inc | 1,732,324 | 1.01% | $20.08M | +1,140,612 | 0.00% |
| Nuveen, LLC | 1,723,979 | 1.00% | $19.98M | +1,381,290 | 0.00% |
| Voloridge Investment Management, LLC | 1,602,916 | 0.93% | $18.58M | New | 0.08% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 197 | 151M | 88.3% | 51 / 73 | 50 / 15 | 38M | 13M |
| Q1 2026 | 164 | 126M | 73.5% | 42 / 54 | 39 / 17 | 23M | 11M |
| Q4 2025 | 143 | 122M | 71.2% | 22 / 52 | 31 / 20 | 30M | 5M |
| Q3 2025 | 142 | 97M | 56.4% | 28 / 52 | 33 / 16 | 16M | 9M |
| Q2 2025 | 131 | 90M | 52.2% | 16 / 56 | 34 / 23 | 9M | 5M |
| Q1 2025 | 139 | 86M | 49.8% | 34 / 49 | 32 / 26 | 20M | 8M |
| Q4 2024 | 133 | 74M | 43.1% | 36 / 42 | 33 / 22 | 9M | 7M |
| Q3 2024 | 122 | 72M | 42.2% | 29 / 33 | 34 / 16 | 15M | 6M |
| Q2 2024 | 111 | 68M | 39.6% | 30 / 40 | 23 / 32 | 17M | 10M |
| Q1 2024 | 114 | 61M | 35.4% | 53 / 30 | 14 / 6 | 28M | 1M |
| Q4 2023 | 67 | 34M | 19.7% | 20 / 21 | 13 / 13 | 3M | 3M |
| Q3 2023 | 60 | 34M | 19.5% | 7 / 17 | 18 / 15 | 1M | 2M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of ABSI | Value | % of fund | As of |
|---|---|---|---|---|---|
| ARK Genomic Revolution ETF | 10,287,893 | 5.99% | $80.04M | 5.14% | Jul 31, 2026 |
| Fidelity Growth Company Fund | 7,213,546 | 4.20% | $48.69M | 0.05% | May 31, 2026 |
| State Street(R) SPDR(R) S&P(R) Biotech ETF | 5,171,464 | 3.01% | $59.94M | 0.56% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 4,407,685 | 2.57% | $51.09M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 3,550,981 | 2.07% | $41.16M | 0.05% | Jun 30, 2026 |
| Columbia Acorn Fund | 2,889,066 | 1.68% | $33.48M | 1.21% | Jun 30, 2026 |
| Columbia Small Cap Growth Fund | 2,266,389 | 1.32% | $15.30M | 0.42% | May 31, 2026 |
| Fidelity Growth Company K6 Fund | 2,262,172 | 1.32% | $15.27M | 0.06% | May 31, 2026 |
| Fidelity Series Growth Company Fund | 1,971,986 | 1.15% | $13.31M | 0.05% | May 31, 2026 |
| Vanguard Extended Market Index Fund | 1,576,119 | 0.92% | $18.27M | 0.02% | Jun 30, 2026 |
| Select Biotechnology Portfolio | 1,540,796 | 0.90% | $10.40M | 0.20% | May 31, 2026 |
| Fidelity Small Cap Index Fund | 1,514,965 | 0.88% | $11.79M | 0.03% | Jul 31, 2026 |
| iShares Russell 2000 Growth ETF | 1,066,503 | 0.62% | $12.36M | 0.08% | Jun 30, 2026 |
| Nuveen Quant Small Cap Equity Fund | 975,490 | 0.57% | $7.59M | 0.19% | Jul 31, 2026 |
| iShares Biotechnology ETF | 942,544 | 0.55% | $10.92M | 0.12% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Sean McClain | Chief Executive Officer, Director | 10,925,542 | 6.37% | Jun 26, 2026 |
| Zachariah Jonasson | CFO / CBO | 483,144 | 0.28% | Sep 1, 2026 |
| Ransi Mudalinayake Somaratne | CMO, Head of R&D | – | – | Aug 7, 2026 |
| Todd Bedrick | SVP, CAO | 216,942 | 0.13% | Mar 16, 2026 |
| Shelby J. Walker | Chief Legal Officer | 139,775 | 0.08% | Mar 16, 2026 |
| Andreas Busch | Chief Innovation Officer | 421,446 | 0.25% | Mar 16, 2026 |
| Mary T. Szela | Director | 21,300 | 0.01% | Jul 6, 2026 |
| Karen K. McGinnis | Director | 48,420 | 0.03% | Jun 11, 2026 |
| Menelas N. Pangalos | Director | 242,408 | 0.14% | Jun 8, 2026 |
| Daniel A. Rabinovitsj | Director | 33,420 | 0.02% | Jun 8, 2026 |
| Joseph Sirosh | Director | 33,420 | 0.02% | Jun 8, 2026 |
| Houten Frans Van | Director | 73,420 | 0.04% | Jun 8, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Zachariah Jonasson CFO / CBO | Aug 31, 2026 | Tax withholding | −8,320 | $8.71 | $72.47K | 483,144 |
| Mary T. Szela Director | Jun 30, 2026 | Buy | +12,900 | $11.54 | $148.87K | 21,300 |
| Sean McClain Chief Executive Officer, Director | Jun 24, 2026 | Tax withholding | −59,896 | $10.08 | $603.75K | 8,655,555 |
| Mary T. Szela Director | Jun 4, 2026 | Award | +8,400 | – | – | 8,400 |
| Karen K. McGinnis Director | Jun 4, 2026 | Award | +10,100 | – | – | 48,420 |
| Mary T. Szela Director | Jun 4, 2026 | Award | +10,100 | – | – | 10,100 |
| Menelas N. Pangalos Director | Jun 4, 2026 | Award | +10,100 | – | – | 242,408 |
| Houten Frans Van Director | Jun 4, 2026 | Award | +10,100 | – | – | 73,420 |
| Daniel A. Rabinovitsj Director | Jun 4, 2026 | Award | +10,100 | – | – | 33,420 |
| Joseph Sirosh Director | Jun 4, 2026 | Award | +10,100 | – | – | 33,420 |
| Zachariah Jonasson CFO / CBO | May 31, 2026 | Tax withholding | −8,319 | $6.75 | $56.15K | 491,464 |
| Menelas N. Pangalos Director | May 13, 2026 | Buy | +37,453 | $5.36 | $200.75K | 232,308 |
| Andreas Busch Chief Innovation Officer | Mar 12, 2026 | Buy | +100,000 | $2.29 | $229.00K | 421,446 |
| Sean McClain Chief Executive Officer, Director | Mar 3, 2026 | Tax withholding | −25,316 | $2.80 | $70.88K | 8,715,451 |
| Shelby J. Walker Chief Legal Officer | Mar 3, 2026 | Tax withholding | −9,825 | $2.80 | $27.51K | 139,775 |
| Todd Bedrick SVP, CAO | Mar 3, 2026 | Tax withholding | −5,282 | $2.80 | $14.79K | 216,942 |
| Zachariah Jonasson CFO / CBO | Mar 3, 2026 | Tax withholding | −10,848 | $2.80 | $30.37K | 499,783 |
| Sean McClain Chief Executive Officer, Director | Mar 3, 2026 | Tax withholding | −25,316 | $2.80 | $70.88K | 8,715,451 |
| Todd Bedrick SVP, CAO | Mar 3, 2026 | Tax withholding | −5,282 | $2.80 | $14.79K | 216,942 |
| Shelby J. Walker Chief Legal Officer | Mar 3, 2026 | Tax withholding | −9,825 | $2.80 | $27.51K | 139,775 |
| Andreas Busch Chief Innovation Officer | Mar 3, 2026 | Tax withholding | −1,257 | $2.80 | $3.52K | 321,446 |
| Zachariah Jonasson CFO / CBO | Mar 3, 2026 | Tax withholding | −10,848 | $2.80 | $30.37K | 499,783 |
| Sean McClain Chief Executive Officer, Director | Mar 2, 2026 | Award | +406,200 | – | – | 8,740,767 |
| Shelby J. Walker Chief Legal Officer | Mar 2, 2026 | Award | +90,300 | – | – | 149,600 |
| Todd Bedrick SVP, CAO | Mar 2, 2026 | Award | +49,600 | – | – | 222,224 |
| Zachariah Jonasson CFO / CBO | Mar 2, 2026 | Award | +135,400 | – | – | 510,631 |
| Menelas N. Pangalos Director | Mar 2, 2026 | Award | +5,800 | – | – | 194,855 |
| Sean McClain Chief Executive Officer, Director | Mar 2, 2026 | Award | +406,200 | – | – | 8,740,767 |
| Todd Bedrick SVP, CAO | Mar 2, 2026 | Award | +49,600 | – | – | 222,224 |
| Shelby J. Walker Chief Legal Officer | Mar 2, 2026 | Award | +90,300 | – | – | 149,600 |
| Zachariah Jonasson CFO / CBO | Mar 2, 2026 | Award | +135,400 | – | – | 510,631 |
| Zachariah Jonasson CFO / CBO | Mar 2, 2026 | Tax withholding | −8,307 | $2.74 | $22.76K | 375,231 |
| Menelas N. Pangalos Director | Feb 27, 2026 | Buy | +75,095 | $2.74 | $205.76K | 189,055 |
| Sean McClain Chief Executive Officer, Director | Feb 23, 2026 | Tax withholding | −267,008 | $2.65 | $707.57K | 8,463,958 |
| Sean McClain Chief Executive Officer, Director | Feb 23, 2026 | Option exercise | +396,399 | $1.21 | $479.64K | 8,730,966 |
| Andreas Busch Chief Innovation Officer | Feb 3, 2026 | Tax withholding | −1,469 | $2.99 | $4.39K | 322,703 |
| Zachariah Jonasson CFO / CBO | Feb 2, 2026 | Tax withholding | −17,496 | $2.99 | $52.31K | 383,538 |
| Sean McClain Chief Executive Officer, Director | Feb 2, 2026 | Tax withholding | −26,761 | $2.99 | $80.02K | 8,334,567 |
| Zachariah Jonasson CFO / CBO | Feb 2, 2026 | Sale | −17,496 | $2.99 | $52.31K | 383,538 |
| Todd Bedrick SVP, CAO | Feb 2, 2026 | Tax withholding | −3,659 | $2.99 | $10.94K | 172,624 |
| Sean McClain Chief Executive Officer, Director | Feb 2, 2026 | Sale | −26,761 | $2.99 | $80.02K | 8,334,567 |
| Todd Bedrick SVP, CAO | Jan 28, 2026 | Award | +15,000 | – | – | 176,283 |
| Houten Frans Van Director | Dec 5, 2025 | Buy | +40,000 | $3.72 | $148.80K | 63,320 |
| Zachariah Jonasson CFO / CBO | Nov 30, 2025 | Tax withholding | −8,320 | $3.17 | $26.37K | 401,034 |
| Andreas Busch Chief Innovation Officer | Oct 14, 2025 | Tax withholding | −3,092 | $3.68 | $11.38K | 324,172 |
| Zachariah Jonasson CFO / CBO | Oct 14, 2025 | Tax withholding | −387 | $3.68 | $1.42K | 409,354 |
| Sean McClain Chief Executive Officer, Director | Oct 14, 2025 | Tax withholding | −23,293 | $3.68 | $85.72K | 8,361,328 |
| Todd Bedrick SVP, CAO | Oct 14, 2025 | Tax withholding | −21,950 | $3.68 | $80.78K | 161,283 |
| Menelas N. Pangalos Director | Sep 22, 2025 | Buy | +95,785 | $2.66 | $254.79K | 113,960 |
| Todd Bedrick SVP, CAO | Sep 22, 2025 | Buy | +10,000 | $2.70 | $27.00K | 180,428 |
| Zachariah Jonasson CFO / CBO | Aug 31, 2025 | Tax withholding | −8,319 | $2.39 | $19.88K | 409,741 |
| Andreas Busch Chief Innovation Officer | Jul 28, 2025 | Buy | +50,000 | $3.04 | $152.00K | 327,264 |
| Houten Frans Van Director | Jun 11, 2025 | Award | +14,500 | – | – | 23,320 |
| Karen K. McGinnis Director | Jun 11, 2025 | Award | +14,500 | – | – | 38,320 |
| Joseph Sirosh Director | Jun 11, 2025 | Award | +14,500 | – | – | 23,320 |
| Menelas N. Pangalos Director | Jun 11, 2025 | Award | +14,500 | – | – | 18,175 |
| Daniel A. Rabinovitsj Director | Jun 11, 2025 | Award | +14,500 | – | – | 23,320 |
| Zachariah Jonasson CFO / CBO | May 31, 2025 | Tax withholding | −5,194 | $2.65 | $13.76K | 418,060 |
| Andreas Busch Chief Innovation Officer | Mar 3, 2025 | Award | +23,700 | – | – | 277,264 |
| Todd Bedrick SVP, CAO | Mar 3, 2025 | Award | +29,700 | – | – | 167,827 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Jonasson Zachariah Officer | Jun 13, 2024 | 19,859 | $98.89K | Jun 13, 2024 | Stock Option Exercise |